During hyperglycemia, glucose increments lower in patients with obesity, T2DM than in lean participants
MONDAY, Nov. 20, 2017 (HealthDay News) — The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus (T2DM), according to a study published online Oct. 19 in JCI Insight.
Janice J. Hwang, M.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues conducted 1H magnetic resonance spectroscopy scanning of the occipital lobe to measure the change in intracerebral glucose levels during a two-hour hyperglycemic clamp (glucose ~220 mg/dl) among 25 participants (nine healthy participants, 10 obese participants without diabetes, and six patients with poorly controlled, insulin- and metformin-treated T2DM).
The researchers found that after they controlled for age and sex, despite similar plasma glucose levels at baseline and during hyperglycemia, the change in intracerebral glucose was significantly different across groups. Brain glucose increments were lower in participants with obesity and T2DM compared with lean participants. In addition, during hyperglycemia, the change in brain glucose was inversely correlated with plasma free fatty acid levels.
“These data suggest that obesity and poorly controlled T2DM progressively diminish brain glucose responses to hyperglycemia, which has important implications for understanding not only the altered feeding behavior, but also the adverse neurocognitive consequences associated with obesity and T2DM,” conclude the authors.
Several authors disclosed financial ties to the pharmaceutical industry.
Copyright © 2017 HealthDay. All rights reserved.
